UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 8, 2017

Accession Number:	0001104659-17-055232
Submission Type:	POS AM
CIK: 0001638287 Company Name: Gemphire Therapeutics Inc. File Number: 333-217296